Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04917055 · ClinicalTrials.gov registry record · Phase 4
iPACK Block With Dexamethasone For Total Knee Replacement
A Phase 4 study, sponsored by University of California, San Diego.
- Terminated
- Registry status
- Phase 4
- Development phase
- 14
- Enrollment target
NCT04917055 is a Phase 4 study that was terminated before completion, run by University of California, San Diego. The registered enrollment target is 14 participants.
The verdict
NCT04917055, a Phase 4 study, was terminated before completion, sponsored by University of California, San Diego.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 14 participants
- Enrollment target
Study Summary
Comparing the pain control outcomes for patients undergoing total knee arthroplasty (TKA) with either: 1) adductor canal single shot injection plus placebo iPACK injection or 2) adductor canal single shot injection plus bupivacaine and dexamethasone iPACK injection. There are two surgical approaches for TKA 1) open 2) ROSA robotic assisted. Both follow the same pain management pathway. We plan to enroll patient undergoing either surgical procedure.
Interventions
- DRUG Saline
- DRUG ropivacaine 0.25% with epinephrine and 6mg dexamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2021-06-07 |
| Est. Completion | 2022-06-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04917055
The ClinicalTrials.gov registry entry for NCT04917055 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT04917055 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04917055 about?
NCT04917055 is a clinical study titled "iPACK Block With Dexamethasone For Total Knee Replacement". Comparing the pain control outcomes for patients undergoing total knee arthroplasty (TKA) with either: 1) adductor canal single shot injection plus placebo iPACK injection or 2) adductor canal single shot injection plus bupivacaine and dexamethasone iPACK injection. There are two surgical approache...
What is the current status of trial NCT04917055?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 14 participants. The study started on 2021-06-07. Estimated completion is 2022-06-07.
What interventions are being tested in trial NCT04917055?
The interventions under investigation include: Saline (DRUG), ropivacaine 0.25% with epinephrine and 6mg dexamethasone (DRUG).
Who is sponsoring clinical trial NCT04917055?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.